Literature DB >> 8099990

Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups.

R M MacKie1, P McHenry, D Hole.   

Abstract

In 1983 a classification scheme was proposed for patients with atypical naevi, according to their personal and family history of melanoma and atypical naevi. To assess the predictive value of these features we undertook prospective surveillance of patients at high risk of primary melanoma. We followed up 116 patients each with 3 or more clinically atypical naevi for at least 5 years. Patients are examined and naevi are photographed every 3-6 months; lesions showing disturbing change are excised for histopathology. Among 85 patients with no personal or family history of melanoma, 5 invasive (level 2 or deeper) melanomas developed during 583 person-years of follow up. The expected number of invasive melanomas in this population would be 0.054; the increased risk is significant (p < 0.001; relative risk 92 [95% CI 30-216]). There was a similarly increased risk of new melanoma also among 24 patients with atypical naevi plus a history of previous melanoma (observed 2, expected 0.022, p < 0.001; relative risk 91 [11-328]). By comparison, no second melanoma developed among 25 patients with previous melanoma but a normal naevus pattern during 213 person-years of similarly intensive follow-up. The risk of melanoma was highest among 7 patients with atypical naevi and a family history of melanoma (observed 6, expected 0.009, p < 0.001; relative risk 444 [121-1138]). The median thickness of surveillance-detected melanomas was 0.75 mm (range 0.40-1.05 mm) in this group. This study shows the value of clinical follow-up of high-risk patients to detect early thin melanomas.

Entities:  

Mesh:

Year:  1993        PMID: 8099990     DOI: 10.1016/0140-6736(93)90758-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Skin cancer-related prevention and screening behaviors: a review of the literature.

Authors:  Nadine A Kasparian; Jordana K McLoone; Bettina Meiser
Journal:  J Behav Med       Date:  2009-06-12

Review 2.  Moles and melanoma--new method in the madness.

Authors:  R L Barnhill
Journal:  West J Med       Date:  1994-04

3.  Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

Authors:  A van Elsas; S F Zerp; S van der Flier; K M Krüse; C Aarnoudse; N K Hayward; D J Ruiter; P I Schrier
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma.

Authors:  Agnessa Gadeliya Goodson; Scott R Florell; Mark Hyde; Glen M Bowen; Douglas Grossman
Journal:  Dermatol Surg       Date:  2010-07       Impact factor: 3.398

5.  Independent validation of six melanoma risk prediction models.

Authors:  Catherine M Olsen; Rachel E Neale; Adèle C Green; Penelope M Webb; David C Whiteman
Journal:  J Invest Dermatol       Date:  2014-12-30       Impact factor: 8.551

6.  Total body photography for skin cancer screening.

Authors:  Lynn T Dengel; Gina R Petroni; Joshua Judge; David Chen; Scott T Acton; Anneke T Schroen; Craig L Slingluff
Journal:  Int J Dermatol       Date:  2014-12-16       Impact factor: 2.736

7.  The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia.

Authors:  V Bataille; A Grulich; P Sasieni; A Swerdlow; J Newton Bishop; W McCarthy; P Hersey; J Cuzick
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

Review 8.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

9.  Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies.

Authors:  Durga Udayakumar; Hensin Tsao
Journal:  Genome Med       Date:  2009-10-27       Impact factor: 11.117

10.  A melanoma risk score in a Brazilian population.

Authors:  Lucio Bakos; Simeona Mastroeni; Renan Rangel Bonamigo; Franco Melchi; Paolo Pasquini; Cristina Fortes
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.